| ONSAGE PFIZER INC.
1956449 10 Apr 2019 | on 25 Jul 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of: psychiatric diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease; pharmaceutical preparations for the treatment of growth and thyroid disorders; pharmaceutical preparations for the treatment of seizures; pharmaceutical preparations for the treatment of neuromuscular diseases and disorder, namely, brain, central nervous system, muscle, ocular motility and spinal cord infections, injuries and diseases; pharmaceutical preparations for the treatment of degenerative nerve diseases; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of cranial and facial nerve disorders; pharmaceutical preparations for the treatment of tissue injuries, and bone and cartilage injuries, diseases and disorders; pharmaceutical preparations for the treatment of pelvic, urological and reproductive system diseases and disorders, namely infections, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence; pharmaceutical preparations for the treatment of auto-immune, cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders; pharmaceutical preparations for the relief of allergies, hypertension, menopause and pain; antibiotics and anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectectible contraceptives, human vaccines and smoking cessation medications | | | ONSAGE PFIZER INC.
1825869 06 Mar 2017 | on 12 Dec 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of vaso-occlusive crisis (VOC); pharmaceutical preparations for the treatment of sickle cell disease | | | ONSAGE PFIZER INC.
1617146 06 Mar 2013 | on 29 May 2019 | Class 005 Class 005 Pharmaceutical Products (1)pharmaceutical preparations for the treatment of: psychiatric diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease, (2) pharmaceutical preparations for the treatment of growth and thyroid disorders;(3) pharmaceutical preparations for the treatment of seizures;(4) pharmaceutical preparations for the treatment of neuromuscular diseases and disorder, namely, brain, central nervous system, muscle, ocular motility and spinal cord infections, injuries and diseases;(5) pharmaceutical preparations for the treatment of degenerative nerve diseases;(6) pharmaceutical preparations for the treatment of multiple sclerosis;(7) pharmaceutical preparations for the treatment of cranial and facial nerve disorders;(8) pharmaceutical preparations for the treatment of tissue injuries, and bone and cartilage injuries, diseases and disorders; (9) pharmaceutical preparations for the treatment of pelvic, urological and reproductive system diseases and disorders, namely infections, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence;(10) pharmaceutical preparations for the treatment of auto-immune, cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders;(11) pharmaceutical preparations for the relief of allergies, hypertension, menopause and pain;(12) antibiotics and anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectectible contraceptives, human vaccines and smoking cessation medications. | | | ONSAGE WYETH LLC
A DELAWARE LIMITED LIABILITY COMPANY
1347725 16 May 2007 | on 05 Jun 2013 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely Alzheimer's disease. | | 
